SenesTech, Inc. (SNES) stock
Close on Nov 11, 2026Market cap $4.84MP/E –Yield –
SenesTech, Inc. grew revenue 13.4% to $2.37M over the twelve months to Jun 30, 2026. Free cash flow was -$6.74M. At the latest close the market valued the company at $4.84M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $4.84M
- P/E ratio
- –
- Price to sales
- 2.04
- Price to book
- 0.80
- Dividend yield
- –
- Free cash flow yield
- -139.14%
Fundamentals
- Revenue
- $2.37M
- Net income
- -$7.00M
- EPS, diluted
- -$1.95
- Free cash flow
- -$6.74M
- Book value per share
- $1.14
- Diluted shares
- 5M
Trading
- Next earnings
- Mar 11, 2027 (estimated, after the close)
- Previous close
- $1.03
- Open
- $0.97
- Day's range
- $0.77 – $1.13
- Volume
- 157,038
- Average volume (20 days)
- 3,259,909
- Beta (5 years)
- 0.84
- 52-week range
- $0.55 – $3.40
- RSI (14 days)
- 46.5
- Volatility (1 year)
- 90.4%
- Relative volume
- 0.20×
- WACC
- 9.1%
Market cap history
Month-end market cap since 2016, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | SNES | S&P 500 | Difference | SNES per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +33.3% | -2.4% | +35.7 pts | ||
| 3 months | -29.2% | -1.2% | −28.0 pts | ||
| Year to date | -58.3% | +12.3% | −70.6 pts | ||
| 1 year | -72.1% | +12.4% | −84.5 pts | ||
| 3 years | -96.9% | +78.8% | −175.7 pts | -68.5% | +21.4% |
| 5 years | -100.0% | +75.2% | −175.1 pts | -81.2% | +11.9% |
Twelve years at a glance
Fiscal years 2014 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases SenesTech filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Results
- Results
About SenesTech
Agricultural Chemicals
SenesTech, Inc. develops and commercializes non-lethal pest management products that control rodent populations through fertility reduction. Its primary commercial offerings include Evolve, a soft bait line utilizing cottonseed oil that features Evolve Rat and Evolve Mouse, and ContraPest, a liquid bait formulation targeting male and female rat reproductive systems. The company serves clients across multiple distribution channels and target verticals, including agribusiness, professional pest management, industrial facilities, retail, and e-commerce markets.
Company profile, executives and historySenesTech stock: common questions
What is SenesTech's stock price?
SNES closed at $0.89 on Nov 11, 2026, down 13.34% on the day. Over the past 52 weeks it traded between $0.55 and $3.40.
What is SenesTech's market cap?
SenesTech was worth $4.84M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is SNES's P/E ratio?
SenesTech lost money over fiscal 2025 (diluted EPS -$1.95), so it has no meaningful P/E ratio.
How much revenue does SenesTech make?
SenesTech reported revenue of $2.37M for the twelve months to Jun 30, 2026, up 13.4% from a year earlier.
Does SenesTech pay a dividend?
No. SenesTech has not paid a cash dividend over the last twelve months.
When does SenesTech report earnings next?
SenesTech is expected to report Q4 FY2026 results on Mar 11, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has SNES stock performed over the past year?
Including dividends, SNES returned -72.1% over the past year, against +12.4% for the S&P 500.
How many SNES shares are sold short?
0M shares were sold short at the latest FINRA report, 1.44% of the float, or 1.0 days of average trading volume.
Who are SenesTech's competitors?
Companies most similar to SenesTech by business, industry and size include EVGN, CBUS, PURE, CITR, XAGE.
See a number that looks wrong?